Whereas some authors [43,49] reported reliable IHC modalities in high-grade serous ovarian carcinomas, others [41,52,53] argue that IHC staining is not robust enough to be used as a screening test for detection of BRCA1 dysfunction. Here, BRCA1 is linked to ovarian serous carcinoma.